Our quality policy is to achieve customer satisfaction, through the development of a sustainableRead More
APL has two manufacturing units with the latest state-of-the-art, most modern manufacturingRead More
R & D
Our R & D is constantly focused on development of new molecules and efficiency improvement ....Read More
To be recognized as a one of the leading Global manufacturers of Quality Active Pharmaceutical Ingredients and their Intermediates
- Certificate of Suitability (COS) for Cetirizine Di HCl, Losartan Potassium & Fluconazole from EDQM during 2011.
- Full scale commercialization of 3rd manufacturing block at Unit-II during calendar year 2011.
- Full scale commercialization multipurpose 4th Manufacturing Block at Unit-II during the calendar year 2010
- Audit & Approvals of Vizag Facility by South Korean FDA during Juluy’2009
- Filing of DMF’s for APIs in Regulated and Semi Regulated Markets.
- WHO GMP Certification of Unit-IIduring Dec’2008.
- Auctus Pharma Pvt.Ltd converted into a Limited Company effective from 13th July,2007 and became Auctus Pharma Limited
- Dr. Mohan, a Doctorate in Organic Chemistry joined as Director from 04.04.2007
- Merger of Neo Medichem Pvt.Ltd has been merged into Auctus Pharma Limited by the Order of High Court dated.26.02.2008 effective from 01.04.2007.
- ISO 9001:2000 Certification of NMPL on April, 2006 from AQA International LLC., USA.
- WHO GMP Certification of NMPL in the month of September, 2004.
- Acquisition of M/s.Sharp Organics Pvt.Ltd and re-naming as M/s.Auctus Pharma Pvt.Ltd in Aug’2003.
- Acquisition of Neo Medichem Pvt Ltd (NMPL) in November, 2002